NXT-Dx
A private company specialized in next generation sequencing methylation analysis through MBD-based Genome-Wide Methylation Sequencing (Chip Seq) and Bisulphite sequencing.
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|
EBITDA | - | - | <1m | <1m | (<1m) | (<1m) | - |
Profit | <1m | <1m | <1m | <1m | (<1m) | (<1m) | (<1m) |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Acquisition | ||
Total Funding | - |
Related Content
Recent News about NXT-Dx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.